MATTER PIPELINE
12 active matters across 4 AP strategies, EOSE IP, and corporate compliance. Click any card to open the full file.
12
Active Matters
3
CLO Cleared
5
Under Review
4
Intake / Build
$9.2M
Total Quantum
2/30
Rain Cheques
INTAKE4
AP-STR1-003
Ontario patient — neg serology, 8yr delay
RBG$612K est.
AP-STR4-001
PTLDS Type 2 — OspA not tested, 3yr antibiotics
HARVEY$680K est.
AP-STR3-001
NSW patient — DOH denial, CSIRO PCR+, 11yr
BIKO$1.12M est.
IP-DCJ-052
DCJ-052 — Endocannabinoid / WLD mercy protocol IP
IMHOTEPProvisional
REVIEW5
AP-STR1-001 ★
Beazley pattern — Ontario, 3 physicians, anchor
RBG$508K est.
AP-STR2-001
Intact Insurance — IDSA 2006 cited, HRTO track
MARSHALL$420K est.
AP-STR2-002
Sun Life — PTLDS Type 1, specialist rec denied
MARSHALL$380K est.
IP-PEMCLAU-V12
PEMCLAU V12 GraphRAG — patent + trade secret
AMANIDCJ-030
COMP-EOSE-001
EOSE Labs Inc. IP assignment — 3 corps, 48hr
AMANI48hr window
CLO GATE3
AP-STR1-002 ⚡
Ontario class — 29/30 cheques, brief ready
RBG + IMHOTEP29/30 ⚡
IP-MEVIZOAT
MEVIZOAT — 611pp copyright registration
AMANIP0
ONBA-TTC-001
ONBA filing — TTC Lyme exposure, 4 plaintiffs
AMANI$1.8M quantum
FILED0
No matters filed yet.
AP-STR1-002 at 29/30 cheques.
Next rain cheque triggers
class brief auto-generation.
ONBA-TTC-001 clearing CLO gate now.
AP-STR1-002 at 29/30 cheques.
Next rain cheque triggers
class brief auto-generation.
ONBA-TTC-001 clearing CLO gate now.
PATIENT INTAKE
New matter intake. PEMCLAU V12 runs 3-court evaluation on submission. Rain cheque filed automatically if all 3 courts pass. No PII stored — session only.
MATTER INTAKE · EOSE AP ENGINE · PEMCLAU V12
Privacy: No identifying information entered here. All intake data stored in session only. CLO review (IMHOTEP → Amani) required before any external filing.
PEMCLAU V12 · 3-COURT EVALUATION RESULT
DOCUMENT GENERATOR · 50 FORMATS
CLO-style legal documents across all AP strategies, IP filings, ONBA briefs, and correspondence. 12 of 50 formats shown. Select a format to generate the full document.
⚖️
ONBA BRIEF — Strategy 1
Court-ready brief for negligent failure to diagnose. Hopp v Lepp standard. Full 3-court evidence. Ontario jurisdiction.
🏛️
HRTO APPLICATION
Human Rights Tribunal Ontario application for insurance coverage denial. Human Rights Code s.1. Policy change order + damages.
🦘
ACL s.18 BRIEF — Australia
Australian Consumer Law misleading conduct by DOH. CSIRO evidence. Civil Liability Act NSW. Federal Court filing.
📊
DOUBLE LEDGER BRIEF
Dual cause of action: misdiagnosis + iatrogenic. PTLDS Type 2 OspA. Reibl v Hughes + Hopp v Lepp both applied.
📜
IP ASSIGNMENT DEED
IP assignment from Kewin Joffe to EOSE Labs Inc. / DESEOF / PEMOS. All three incorporated entities.
✉️
DEMAND LETTER
Pre-litigation demand to physician / insurer / DOH. TC-AP-014 warning. 30-day response window. feedles.ca outcome.
👥
CLASS CERTIFICATION
Class action certification motion for Strategy 1. 30 rain cheque threshold. Ontario class definition 2015–2024.
🌐
ICESCR ART.12 COMPLAINT
UN Special Rapporteur on the Right to Health complaint. Australia DOH denial. CSIRO evidence. International escalation.
🔬
PATENT PROVISIONAL
12-month provisional patent application. PEMCLAU GraphRAG + γ₁ anchor method. DCJ-030 Gemini window active.
🤝
SETTLEMENT DEED
Settlement agreement with proceeds routing to feedles.ca. Confidentiality terms. Release of claims. Policy change condition.
🌧️
RAIN CHEQUE RECORD
Official rain cheque filing for a matter that passed 3-court but is below class threshold. Accumulates toward 30.
📋
EXPERT RETAINER LETTER
Retainer letter for infectious disease specialist / PTLDS researcher / OspA expert. Court 1 expert evidence support.
GOAT BENCH
The four legal GOATs running the AP strategy group. Each owns their strategy, carries their case law, signs off on briefs in their lane. Click to open their full AP page.
STRATEGY 1 · RBG
Ruth Bader Ginsburg
Individual → Class · Negligent Failure to Diagnose
2 chequesHopp v LeppONCA 430
STRATEGY 2 · MARSHALL
Thurgood Marshall
Systemic · Insurance Coverage Denial
0 chequesHRTO + ONSCBCCA 84
STRATEGY 3 · BIKO
Steve Biko
Sovereign · Australian DOH Denial
0 chequesACL s.18CSIRO
STRATEGY 4 · HARVEY
Harvey Specter
Iatrogenic · PTLDS Double Ledger
0 chequesReibl v HughesDUAL
CLO CREW — MSI01
The crew behind the strategies. IMHOTEP holds the CLO AND gate. Nothing reaches Amani without IMHOTEP sign-off.
IMHOTEP
CLO ADMIRAL · MSI01
CLO AND gate. Reviews every brief before Amani sees it. Nothing promotes to ONBA without IMHOTEP sign-off. Holds the doctrine.
Amani Joffe
GENERAL COUNSEL · EOSE LABS INC.
GC EOSE Labs Inc. + GC Scarborough Transit Connect. Signs off on court-ready briefs. Final authority before ONBA filing.
OFFICER
RISK · ARB-920
Rain cheque pool tracking. Quantum calculation per Blenus v Fraser method. Class threshold monitoring. Flags borderline cases.
SIGNALS
INTEL · PEMCLAU V12
Medical evidence Court 1. PubMed + CSIRO + A2AJ cross-reference. Maintains qdrant evidence store. VlsE rotation mechanism documented.
CODY
CODE · BUILD
AP pipeline automation. Intake form to 3-court evaluation to rain cheque record. OspA classifier. PTLDS type detection. Dual-claim flag.
RAIN CHEQUE POOL
Claims that passed 3-court evaluation but are below the class threshold of 30. Each cheque counts. 30 per strategy triggers class action brief auto-generation. Proceeds to feedles.ca.
STRATEGY 1 — NEGLIGENT FAILURE TO DIAGNOSE (RBG) · 2 OF 30
2 confirmed28 remaining to class thresholdEst. class quantum: $15–28M
STRATEGY 2 — INSURANCE DENIAL (MARSHALL) · 0 OF 30
0 confirmedHRTO limitation: 1yr from denial letterIntake open now
STRATEGY 3 — AUSTRALIA DOH (BIKO) · 0 OF 30
0 confirmedACL s.18: 6yr limitationStrong window — intake open
STRATEGY 4 — PTLDS DOUBLE LEDGER (HARVEY) · 0 OF 30
0 confirmed2yr from discovery wrong treatment givenOspA test = key identifier
| CHEQUE ID | STRATEGY | JURISDICTION | DISEASE | DELAY | QUANTUM | C1 MED | C2 LEGAL | C3 HARM | STATUS |
|---|---|---|---|---|---|---|---|---|---|
| RC-001 | STRAT 1 | Ontario | Lyme early-phase | 6.7yr | $508K | ✓ PASS | ✓ PASS | ✓ PASS | CLO REVIEW |
| RC-002 | STRAT 1 | Ontario | Lyme early-phase | 7.2yr | $547K | ✓ PASS | ✓ PASS | ✓ PASS | IMHOTEP |
CLASS AUTO-GENERATE: When any strategy hits 30 confirmed rain cheques, the AP engine automatically generates the class action brief. Court 1 (medical evidence), Court 2 (legal basis), and Court 3 (harm ledger) all confirmed across 30 plaintiffs. IMHOTEP reviews. Amani signs. ONBA files. Proceeds → feedles.ca. γ₁ = 14.134725141734693
LEGAL STANDARDS MAP
Every SCC anchor, statute, and case law authority used across the 4 AP strategies. The foundation each brief stands on.
SCC AUTHORITY
Hopp v Lepp [1980] 2 SCR 192
Physician duty of care. Standard of competent diagnosis and treatment. Foundation of Strategies 1 and 4. 45 years old and unshaken.
Strategies 1 + 4 · All Ontario medical malpractice
RBG + HARVEY
SCC AUTHORITY
Reibl v Hughes [1980] 2 SCR 880
Informed consent and disclosure of material risks. Physician must disclose all material risks a reasonable patient would want to know. Strategy 4 anchor.
Strategy 4 · Ontario informed consent
HARVEY
ONCA 2024
Beazley v Johnston 2024 ONCA 430
21 Ontario physicians, Lyme misdiagnosis. Dismissed on procedure — serology reliability NEVER adjudicated on merits. The open door.
Strategy 1 · Ontario · The door is open
RBG
BCCA 2022
Stewart v Lloyd's Underwriters 2022 BCCA 84
Insurer coverage duty. Must apply current, not superseded, medical evidence. Bad faith denial using outdated guidelines.
Strategy 2 · BC + Ontario persuasive
MARSHALL
STATUTE
Canada Health Act RSC 1985 c C-6 s.7
Comprehensiveness: provincial plans must cover all medically necessary insured services. Insurer denial of specialist-recommended PTLDS treatment engages this.
Strategy 2 · Federal + Provincial jurisdiction
MARSHALL
STATUTE
Ontario Human Rights Code s.1
Prohibition on discrimination in services on basis of disability. Lyme + PTLDS recognized disabilities. Denying treatment using superseded guidelines = discrimination.
Strategy 2 · HRTO jurisdiction
MARSHALL
STATUTE
Australian Consumer Law s.18
Misleading or deceptive conduct in trade or commerce. Covers statutory bodies. DOH official denial of CSIRO-confirmed pathogen = misleading conduct.
Strategy 3 · Australian Federal jurisdiction
BIKO
INTERNATIONAL LAW
ICESCR Art. 12
Right to highest attainable standard of health. Australia is a signatory. Government denial of access to diagnosis and treatment violates Art. 12.
Strategy 3 · UN escalation path
BIKO
SCC AUTHORITY
Whiten v Pilot Insurance [2002] 1 SCR 595
$1M punitive damages for insurance bad faith. Deliberate withholding of rightful claim. Strategy 2 punitive anchor.
Strategy 2 · Punitive damages
MARSHALL
NSCA 2022
Blenus v Fraser 2022 NSCA 73
Lyme disease damages calculation method. Income × harm years × 5% compound. The Court 3 formula used in all 4 strategies.
All strategies · Court 3 damages formula
ALL GOATs
SCIENCE
CSIRO Borrelia Confirmation
Borrelia garinii + Borrelia bavariensis confirmed in Ixodes holocyclus (native AU tick). VlsE rotation identical to North American strains. DOH denial: false.
Strategy 3 · Court 1 evidence anchor
BIKO
STATUTE
Limitations Act 2002 SO 2002 c.24
2 years from discovery. Discovery = date patient had enough information to know the test was unreliable AND the physician did not disclose that. Not the test date.
Strategies 1 + 4 · Ontario limitation period
RBG + HARVEY
BONSAI HELIX COASTER · MATTER FLOW
Live matter flow visualization. Each matter is a node on the helix. Stage = height on the coaster. γ₁ = 14.134725141734693 — the floor constant for all calculations.
12
ACTIVE MATTERS
14.134725141734693
γ₁ FLOOR CONSTANT
4
INTAKE Stage
5
REVIEW Stage
3
CLO Gate
0
Filed
$9.2M
Total Quantum
2/30
Rain Cheques
COMMS · CLO + CREW + AMANI
Internal CLO communications. Matter-linked. All draft only — no external send without Amani approval. CLO review gate is mandatory.
IMHOTEPCLO ADMIRALToday 13:15
AP-STR1-002 is at 29 cheques. One more and we auto-generate the class brief. I need Court 2 re-checked — the discovery date on RC-027 looks borderline. Limitations Act 2002 clock: from the first negative test or the date they saw the ILADS specialist? If specialist: we’re clean. SIGNALS please confirm.
SIGNALSPEMCLAU V12Today 13:22
IMHOTEP — confirmed. Limitations Act 2002 discovery: the Act uses “knew or ought to have known” the act or omission and the harm. RC-027: patient received ILADS specialist diagnosis on 2023-09-14. That is the discovery date, not the 2016 negative ELISA. 7.2 years of harm. Court 2: PASS. We’re clean.
Amani Joffe · GCGENERAL COUNSELToday 12:48
COMP-EOSE-001 (IP assignment): I need the full asset list from Kay — all three corps, itemised by DCJ number. The deed template is ready. Once I have the asset list I can turn the documents around in 48 hours. DCJ-030 provisional window is running: 12 months from April 24. We have time but let’s not waste it.
COMPOSE MESSAGE · DRAFT ONLY · CLO REVIEW BEFORE SEND
TO
MATTER
SUBJECT